Original document(8 pages)  中文版
    The present invention relates to a preparation method of liposome as anticancer medicine, whose targetable drug-applied ratio is closed to 100% (direct injection to cancerism). Because three layers (internal, intermediate and external) of the sain liposome are treated specially, so that said liposome is applicable to industrialization production, and as thickening and slow-releasing measures are taken for said liposome, when the drug is directly applied to the focus, its orientation effect is good and action time is long.
Application Number
申请号
92104309 Application Date
申请日
1992.06.01
Title 名称 Method for preparation of liposome of anticancer medicine
Publication Number
公开号
1079385 Publication Date
公开日
1993.12.15
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/127
Applicant(s) Name
申请人
Cong Fanzi
Address 地址 150000
Inventor(s) Name 发明人
Attorney & Agent 代理人

  
Quick-effective aerosol with plant aroma and its preparation
Chinese medicine composition and preparation for treating pelvic inflammation of male and female and its preparing method
Composite biological-product composition based on plant and its preparation method
Self-Service respiratory vaccination instrument for SARS infectious disease
Carrying suppository for cavity/canal drug administration
Method for treating eye diseases including myopia by employing bionic three-in-one integrated approach
Supported suppository adapted for drug administering to cavity and its preparation method
Compound biological product conposition and preparation method thereof
Device for treating eye using bionics method
New application of eyeglasses in procedure of eyesight rehabilitation, preparation method, and method of application
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.